首页> 外文期刊>Disease markers >Prognostic markers in patients with ascites and hepatorenal syndrome.
【24h】

Prognostic markers in patients with ascites and hepatorenal syndrome.

机译:腹水和肝肾综合征患者的预后指标。

获取原文
获取原文并翻译 | 示例
           

摘要

Cirrhosis is a progressive liver disorder characterized by a distorted liver architecture due to fibrosis which eventually leads to portal hypertension. It is a common cause of mortality accounting for over 26,000 deaths annually in the United States [1]. The natural course of patients with cirrhosis is frequently complicated by the accumulation of fluid in the peritoneal space in the form of ascites. This is caused by an abnormal regulation of extracellular fluid volume which leads to alterations in renal function with renal sodium retention, solute-free water retention, and renal vasoconstriction. These changes are responsible for fluid accumulation in the form of ascites, dilutional hyponatremia and hep-atorenal syndrome (HRS) respectively. Ascites is the most common complication of cirrhosis and poses and increased risk for infections, renal failure and mortality.
机译:肝硬化是一种进行性肝病,其特征是由于纤维化导致肝脏结构变形,最终导致门脉高压。它是导致死亡的常见原因,在美国每年造成超过26,000人死亡[1]。肝硬化患者的自然病程常常由于腹水形式的腹膜腔积液而变得复杂。这是由于细胞外液量的异常调节导致的,其导致肾功能改变,包括肾钠retention留,无溶质水retention留和肾血管收缩。这些变化分别导致腹水,稀释性低钠血症和肝-肾上腺综合征(HRS)形式的液体积聚。腹水是肝硬化和姿势最常见的并发症,并增加感染,肾衰竭和死亡的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号